Profile
DNTH VRTX REGN SGEN ARGX ALNY
Company Name Dianthus Therapeutics, Inc. Vertex Pharmaceuticals Incorporated Regeneron Pharmaceuticals, Inc. Seagen Inc. argenx SE Alnylam Pharmaceuticals, Inc.
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology
Market Cap $648.17M $123.21B $77.21B $43.15B $37.83B $31.38B
Employees 0.05K 6.10K 15.11K 3.26K 1.15K 2.23K
CEO Mr. Marino Garcia M.B.A. Dr. Reshma Kewalramani FASN, M.D. Dr. Leonard S. Schleifer M.D., Ph.D. Mr. David R. Epstein B.Sc., M.B.A. Mr. Timothy Van Hauwermeiren EMBA, M.Sc. Dr. Yvonne L. Greenstreet M.B.A., MBChB
Ratings
DNTH VRTX REGN SGEN ARGX ALNY
Quant Rating Score 2 3 4 3 1 1
Quant Rating Sell Neutral Buy Neutral Strong Sell Strong Sell
Trading
DNTH VRTX REGN SGEN ARGX ALNY
Last Close $21.9 $495.42 $689.5 $228.74 $591.45 $242.43
High 52 $31.94 $516.74 $1201.76 $228.74 $671.75 $296.75
Low 52 $19.21 $392.81 $663.86 $228.74 $356.01 $143.31
Price vs. 52 Week High -31.43 % -4.13 % -42.63 % 0 % -11.95 % -18.3 %
Price vs. 52 Week Low 14 % 26.12 % 3.86 % 0 % 66.13 % 69.16 %
Total Return
DNTH VRTX REGN SGEN ARGX ALNY
1 Month Return -9.24 % 7.1 % 2.26 % 0 % -9.19 % -8.48 %
3 Month Return -8.02 % 6.87 % -5.67 % 0 % -2.48 % -1.15 %
6 Month Return -24.38 % 2.07 % -40.22 % 0 % 9.93 % -8.61 %
9 Month Return -18.77 % 3.42 % -32.83 % 0 % 52.3 % 51.47 %
YTD Return 0.46 % 23.02 % -3.2 % 0 % -3.83 % 3.03 %
1 Year Return -25.26 % 19.9 % -28.58 % 0 % 54.93 % 63.34 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
DNTH VRTX REGN SGEN ARGX ALNY
Dividend Yield Percentage (TTM) - - 0.12 % - - -
Dividend Paid and Capex Coverage Ration (TTM) -594.24 % -1.65 % 5.37 % -2.27 % -2.22 % -0.24 %
Dividend Per Share (TTM) - - 0.88 % - - -
Payout Ratio (TTM) - - - - - -
Growth
DNTH VRTX REGN SGEN ARGX ALNY
Asset Growth 115.86 % -0.87 % 44.93 % 10.71 %
Gross Profit Growth -60.59 % 10.25 % 190.7 % 26.81 %
Revenue Growth -55.96 % 11.66 % 198.56 % 22.97 %
Revenue 3 Year - 45.6 % 2071.96 % 145.29 %
Revenue 5 Year - 163.93 % 3041.46 % 769.33 %
Revenue 10 Year - 1632.15 % 9009.53 % 2468.51 %
EBIT Growth -62.17 % -105.41 % 40.94 % 37.31 %
Net Income Growth -52.95 % -114.8 % 58.42 % 36.82 %
Net Income 3 Yeari Growth Per Share 69.04 % -122.89 % 64.01 % 69.96 %
Net Income 5 Yeari Growth Per Share 83.11 % -145.38 % -143.65 % 73.33 %
Net Income 10 Yeari Growth Per Share -98.11 % 33.84 % -857 % 55.42 %
Operating Income Growth -62.17 % -105.41 % 40.94 % 37.31 %
Operating Cash Flow Growth (CFG) -26.8 % -113.93 % 51.28 % -107.98 %
Operating 3 Year CFG 69.33 % -118.65 % 21.71 % 98.81 %
Operating 5 Year CFG 80.37 % -131.3 % -329.63 % 97.46 %
Operating 10 Year CFG -142.18 % 12.43 % -1280.2 % 97.1 %
EPS Growth -11.18 % -114.8 % 60.46 % 38.64 %
EPS Diluted Growth -11.18 % -114.97 % 60.46 % 38.64 %
Book Value Per Share 376.75 % -6.59 % 38.53 % 129.53 %
Share Holder 3 Year Equity Growth Per Share -37.49 % 62.6 % 94.42 % -89.49 %
Share Holder 5 Year Equity Growth Per Share -74.14 % 168.85 % 318.81 % -96.04 %
Share Holder 10 Year Equity Growth Per Share 701.14 % 1265.7 % 3654.06 % -95.86 %
Dividend Per Share Growth - - - -
Dividend 3 Year Growth Per Share - - - -
Dividend 5 Year Growth Per Share - - - -
Dividend 10 Year Growth Per Share - - - -
Debt Growth -25.76 % 116.42 % 60.95 % -51.69 %
Free Cash Flow Growth -26.57 % -124.1 % 51.98 % -201.54 %
Updated On 31 Dec 2023 31 Dec 2024 31 Dec 2023 31 Dec 2024
Profitability
DNTH VRTX REGN SGEN ARGX ALNY
Gross Profit Margin TTM 94.02 % 86.09 % 84.47 % 72.37 % 86.82 % 85.62 %
Return on Assets TTM -18.94 % -2.38 % 11.69 % -11.76 % -2.13 % -6.56 %
Return on Equity TTM -21.68 % -3.28 % 14.77 % -16.53 % -2.75 % 905.33 %
Return on Capital Employed TTM -24.49 % -1.3 % 10.89 % -16.87 % -8.98 % -5.79 %
Net Income Per EBT TTM 100 % -215.53 % 92.32 % 100.55 % 167.72 % 73.71 %
EBT Per Ebit TTM 80.93 % -100.69 % 118.85 % 94.01 % 15.76 % 213.34 %
EBIT Per Revenue TTM -1544.99 % -2.24 % 28.32 % -36.09 % -17.08 % -7.87 %
Cash Flow To Debt Ratio TTM -16050.16 % -28.16 % 222.76 % -185.98 % -428.57 % -0.64 %
Receivables Turnover TTM 4.15 6.84 2.29 1.98 3.45 5.55
Payables Turnover TTM 0.04 3.71 2.79 1.54 1.06 3.66
Inventory Turnover TTM - 1.27 0.71 0.65 0.91 4.12
Fixed Asset Turnover TTM 991.87 % 425.82 % 308.76 % 256.83 % 6116.64 % 323.99 %
Asset Turnover TTM 1.51 % 48.84 % 37.61 % 34.46 % 47.09 % 53.02 %
Operating Cash Flow Per Share TTM -1.46 -1.91 41.08 -1.12 -2.42 -0.06
Free Cash Flow Per Share TTM -1.45 -3.07 33.43 -1.62 -3.52 -0.33
Cash Per Share TTM 821.12 % 2375.11 % 16647.4 % 657.5 % 5163.05 % 2095.42 %
Operating Cash Flow Sales Ratio TTM -930.23 % -4.48 % 31.13 % -16.85 % -6.44 % -0.37 %
Free Cash Flow Operating Cash Flow Ratio TTM 99.78 % 160.43 % 81.38 % 144.14 % 145.12 % 512.38 %
Cash Flow Coverage Ratios TTM -16050.16 % -28.16 % 222.76 % -185.98 % -428.57 % -0.64 %
Price To Free Cash Flows Ratio TTM -13.01 -155.9 21.46 -141.85 -179.11 -736.91
Price To Operating Cash Flows Ratio TTM -15.02 -250.8 17.48 -203.89 -257.05 -3750.49
Price Cash Flow Ratio TTM -15.02 -250.8 17.48 -203.89 -257.05 -3750.49
Income Statement (TTM)
DNTH VRTX REGN SGEN ARGX ALNY
Revenue $0.01B $11.02B $14.2B $1.96B $1.23B $2.25B
Gross Profit $0.01B $9.49B $12.23B $1.55B $1.11B $1.92B
Gross Profit Ratio 100% 86.11% 86.13% 79.1% 90.39% 85.62%
EBITDA $-0.1B $0.49B $5.32B $-0.62B $-0.22B $-0.18B
Net Income $-0.08B $-0.54B $4.41B $-0.61B $-0.3B $-0.28B
EPS Diluted -2.48 -2.08 38.34 -3.3 -5.16 -2.16
Balance Sheet (MRQ)
DNTH VRTX REGN SGEN ARGX ALNY
Long Term Debt $0B $1.66B $2.7B $0.04B $0.02B $0B
Total Liabilities $0.02B $6.12B $8.41B $0.87B $0.44B $4.17B
Total Equity $0.35B $16.41B $29.35B $2.8B $4.1B $0.07B
Total Investments $0.33B $6.65B $6.52B $1.42B $1.18B $1.73B
Total Debt $0B $1.75B $2.7B $0.04B $0.02B $1.3B
Total Assets $0.37B $22.53B $37.76B $3.67B $4.54B $4.24B
Cash Flow Statement (TTM)
DNTH VRTX REGN SGEN ARGX ALNY
Net Income $-0.08B $-0.54B $4.41B $-0.61B $-0.43B $-0.28B
Inventory $0B $-0.52B $-0.62B $-0.23B $-0.08B $0.01B
Dividends Paid $0B $0B $0B $0B $0B $0B
Operating Cash Flow $-0.08B $-0.49B $4.42B $-0.45B $-0.42B $-0.01B
Capital Expenditure $-0B $-0.3B $-0.76B $-0.08B $-0.04B $-0.03B
Related Stocks
Ticker Name Price
AADI Aadi Bioscience, Inc. 1.925
AAPG 18.78
ABCL AbCellera Biologics Inc. 2.395
ABCM Abcam plc 23.99
ABEO Abeona Therapeutics Inc. 5.27
ABIO ARCA biopharma, Inc. 28.8
ABOS Acumen Pharmaceuticals, Inc. 1.225
ABPWW 0.0302
ABSI Absci Corporation 2.905
ABUS Arbutus Biopharma Corporation 3.32
ABVC ABVC BioPharma, Inc. 0.6701
ABVX Abivax SA American Depositary Shares 5.95
ACAD ACADIA Pharmaceuticals Inc. 16.79
ACER Acer Therapeutics Inc. 0.6601
ACET Adicet Bio, Inc. 0.7759
ACGN Aceragen, Inc. 0.3849
ACHL Achilles Therapeutics plc 1.418
ACHV Achieve Life Sciences, Inc. 2.66
ACIU AC Immune SA 2.28
ACLX Arcellx, Inc. 71.62
ETFs With Exposure to DNTH
Ticker ETF Name Weight Percentage Price
IWM iShares Russell 2000 ETF 0.02411 198.1
VTI Vanguard Total Stock Market Index Fund 0 271.11
XBI SPDR S&P Biotech ETF 0.129477 85.99
SCHB Schwab U.S. Broad Market ETF 0.00103843 21.225
ITOT iShares Core S&P Total U.S. Stock Market ETF 0.00113 120.27
SCHA Schwab U.S. Small-Cap ETF 0.0127735 23.17
IWN iShares Russell 2000 Value ETF 0.04519 149.31
IWV iShares Russell 3000 ETF 0.00107 313.1
LABU Direxion Daily S&P Biotech Bull 3X Shares 0.0936127 74.025
IWO iShares Russell 2000 Growth ETF 0.00349 254.56
VHT Vanguard Health Care Index Fund 0 261.72
VXF Vanguard Extended Market Index Fund 0.01 170.17
HDG ProShares Hedge Replication ETF 0.00295162 49.0399
UWM ProShares Ultra Russell2000 0.00825269 33.02
VTHR Vanguard Russell 3000 Index Fund 0 243.21
IWC iShares Micro-Cap ETF 0.16362 112.89
FHLC Fidelity MSCI Health Care Index ETF 0.00342413 67.45
URTY ProShares UltraPro Russell2000 0.00538783 33.93
VTWV Vanguard Russell 2000 Value Index Fund 0.04 131.45
ISCB iShares Morningstar Small-Cap ETF 0.00729 53.5828
ISCG iShares Morningstar Small-Cap Growth ETF 0.01483 44.5
SBIO ALPS Medical Breakthroughs ETF 0.0059 30.54
VFMO Vanguard U.S. Momentum Factor ETF 0.08 147.47
VTWG Vanguard Russell 2000 Growth Index Fund 0 186.86
VTWO Vanguard Russell 2000 Index Fund 0.02 80.09
VITNX Vanguard Institutional Total Stock Market Index Fund Institutional Shares 0 94.11
VITPX Vanguard Institutional Total Stock Market Index Fund Institutional Plus Shares 0 94.09
VBAIX Vanguard Balanced Index Fund Institutional Shares 0 47.4
VBIAX Vanguard Balanced Index Fund Admiral Shares 0 47.39
VBINX Vanguard Balanced Index Fund Investor Shares 0 47.39
SPGM SPDR Portfolio MSCI Global Stock Market ETF 0.0005 61.96
AVUS Avantis U.S. Equity ETF 0 90.73
GINN Goldman Sachs Innovate Equity ETF 0 59.1
DFUS Dimensional U.S. Equity ETF 0.00029302 59.58
DFAT Dimensional U.S. Targeted Value ETF 0.00031658 50.46
DFAS Dimensional U.S. Small Cap ETF 0.00071546 58.76
DFAC Dimensional U.S. Core Equity 2 ETF 0.00010004 32.4051
VTSAX Vanguard Total Stock Market Index Fund 0 133.91
VIEIX Vanguard Extended Market Index Fund Institutional Shares 0.01 131.85
VITSX Vanguard Total Stock Market Index Fund 0 133.94
IBRN iShares Neuroscience and Healthcare ETF 1.14433 23.44
SWTSX Schwab Total Stock Market Index Fd Select Shs a Series of Schwab Capit 0.000158245 94.08
VEXAX Vanguard Extended Market Index Fd Admiral Shs 0.01 131.86
USFM.L UBS (Irl) ETF plc - MSCI USA Select Factor Mix UCITS ETF (USD) A-dis 0 2577.5
VHCIX Vanguard HealthCare Index Fund Admiral Shs 0 131.78
USUE.DE UBS (Irl) ETF plc - MSCI USA Select Factor Mix UCITS ETF (USD) A-acc 0 34.02
AVSC Avantis U.S. Small Cap Equity ETF 0.07 48.07
VEMPX Vanguard Extended Market Index InstlPlus 0.01 325.39
USFMDN.MX UBS (Irl) ETF Public Limited Company - MSCI USA Select Factor Mix UCITS ETF 0 382
VSMPX Vanguard Total Stock Mkt Idx Instl Pls 0 251.25
RSSL Global X Funds 0.02 78.06
RFLR Innovator ETFs Trust 0.03 23.94
Unlock